Trials / Unknown
UnknownNCT01471275
Chinese Medicine Treatment of Obesity With Type 2 Diabetes, Dyslipidemia
The Study of TCM in Prevention and Promote of Community-based Diabetes
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 450 (estimated)
- Sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
With metformin for the control, evaluate the safety and efficacy of Jiangtangtiaozhi decoction in treatment of obesity with type 2 diabetes, dyslipidemia
Detailed description
Waist circumference, body mass index, triglycerides, glycosylated hemoglobin, blood glucose were evaluated; liver function, kidney function, blood, urine, stool, adverse event recording, evaluation of low blood sugar event log security.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin | 250 mg or 500mg three times a day |
| DRUG | Jiangtangtiaozhi decoction | 15 grams each time, twice a day, with boiled water |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2013-09-01
- Completion
- 2013-12-01
- First posted
- 2011-11-15
- Last updated
- 2011-12-06
Locations
8 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01471275. Inclusion in this directory is not an endorsement.